An appropriate inspiratory flow pattern can enhance CO2 exchange, facilitating protective ventilation of healthy lungs

End-Tidal Carbon Dioxide Pressure Measurement after Prolonged Inspiratory Time Gives a Good Estimation of the Arterial Carbon Dioxide Pressure in Mechanically Ventilated Patients

Background: End-tidal carbon dioxide pressure (PetCO₂) is unreliable for monitoring PaCO₂ in several conditions because of the unpredictable value of the PaCO₂–PetCO₂ gradient. We hypothesised that increasing both the end-inspiratory pause and the expiratory time would reduce this gradient in patients ventilated for COVID-19 with Acute Respiratory Distress Syndrome and in patients anaesthetised for surgery. Methods: On the occasion of an arterial blood gas sample, an extension in inspiratory pause was carried out either by recruitment manoeuvre or by extending the end-inspiratory pause to 10 s. The end-expired PCO₂ was measured (expiratory time: 4 s) after this manoeuvre (PACO₂) in comparison with the PetCO₂ measured by the monitor. We analysed 67 Δ(a-et)CO₂, Δ(a-A)CO₂ pairs for 7 patients in the COVID group and for 27 patients in the anaesthesia group. Results are expressed as mean ± standard deviation. Results: Prolongation of the inspiratory pause significantly reduced PaCO₂–PetCO₂ gradients from 11 ± 5.7 and 5.7 ± 3.4 mm Hg (p < 0.001) to PaCO₂–PACO₂ gradients of −1.2 ± 3.3 (p = 0.043) and −1.9 ± 3.3 mm Hg (p < 0.003) in the COVID and anaesthesia groups, respectively. In the COVID group, PACO₂ showed the lowest dispersion (−7 to +6 mm Hg) and better correlation with PaCO₂ (R² = 0.92). The PACO₂ had a sensitivity of 0.81 and a specificity of 0.93 for identifying hypercapnic patients (PaCO₂ > 50 mm Hg). Conclusions: Measuring end-tidal PCO₂ after prolonged inspiratory time reduced the PaCO₂–PetCO₂ gradient to the point of obtaining values close to PaCO₂. This measure identified hypercapnic patients in both intensive care and during anaesthesia.

Lung-protective properties of expiratory flow-initiated pressure-controlled inverse ratio ventilation: A randomised controlled trial

Background

Expiratory flow-initiated pressure-controlled inverse ratio ventilation (EF-initiated PC-IRV) reduces physiological dead space. We hypothesised that EF-initiated PC-IRV would be lung protective compared with volume-controlled ventilation (VCV).

Methods

Twenty-eight men undergoing robot-assisted laparoscopic radical prostatectomy were enrolled in this randomised controlled trial. The EF-initiated PC-IRV group (n = 14) used pressure-controlled ventilation with the volume guaranteed mode. The inspiratory to expiratory (I:E) ratio was individually adjusted by observing the expiratory flow-time wave. The VCV group (n = 14) used the volume control mode with a 1:2 I:E ratio. The Mann–Whitney U test was used to compare differences in the serum cytokine levels.

Results

There were no significant differences in serum IL-6 between the EF-initiated PC-IRV (median 34 pg ml^-1 (IQR 20.5 to 63.5)) and VCV (31 pg ml^-1 (24.5 to 59)) groups (P = 0.84). The physiological dead space rate (physiological dead space/expired tidal volume) was significantly reduced in the EF-initiated PC-IRV group as compared with that in the VCV group (0.31 ± 0.06 vs 0.4 ± 0.07; P<0.001). The physiological dead space rate was negatively correlated with the forced vital capacity (% predicted) in the VCV group (r = -0.85, P<0.001), but not in the EF-initiated PC-IRV group (r = 0.15, P = 0.62). Two patients in the VCV group had permissive hypercapnia with low forced vital capacity (% predicted).

Conclusions

There were no differences in the lung-protective properties between the two ventilatory strategies. However, EF-initiated PC-IRV reduced physiological dead space rate; thus, it may be useful for reducing the ventilatory volume that is necessary to maintain normocapnia in patients with low forced vital capacity (% predicted) during robot-assisted laparoscopic radical prostatectomy.

Monitoring of lung function in acute respiratory distress syndrome

Monitoring of lung function is essential to assess changes in the lung condition, and to correct and improve ventilator and adjuvant therapies in acute respiratory distress syndrome (ARDS). In this review we discuss the use of monitoring of gas exchange, lung mechanics and shortly on lung imaging in this condition.